Screener
Intellia Therapeutics NTLA Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's book value per share?
- Intellia Therapeutics (NTLA) reported book value per share of $5.45 in Q2 2026.
- How has Intellia Therapeutics's book value per share changed year-over-year?
- Intellia Therapeutics's book value per share increased by 179.1% year-over-year, from -$6.90 to $5.45.
- What is the long-term trend for Intellia Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Intellia Therapeutics's book value per share has grown at a -6.3% compound annual growth rate (CAGR), from $8.60 to $6.20.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Intellia Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude